Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Dopamine Receptor D1 ELISA Kit (AC3581)
Cat.#: ASET-2170
Specifications
Description Rat Dopamine Receptor D1 ELISA Kit allows for the in vitro quantitative determination of rat Dopamine Receptor D1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 7.5 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 12.5-800 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1204 Human Wnt5a ELISA Kit (AC2615) Quantitative inquiry ASET-2122 Human COMT ELISA Kit (AC3533) Quantitative inquiry ASET-1795 Guinea Pig beta Nerve Growth Factor ELISA Kit (AC3206) Quantitative inquiry ASET-2255 Mouse Semaphorin 7a ELISA Kit (AC3666) Quantitative inquiry ASET-1187 Rat VAP1 ELISA Kit (AC2598) Quantitative inquiry ASET-1196 Mouse DLL1 ELISA Kit (AC2607) Quantitative inquiry ASET-2291 Human Wnt5a ELISA Kit (AC3702) Quantitative inquiry ASET-2278 Human GAP43 ELISA Kit (AC3689) Quantitative inquiry ASET-1641 Human LRRK2 ELISA Kit (AC3052) Quantitative inquiry ASET-1343 Human Netrin 4 ELISA Kit (AC2754) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket